Mobile

A Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Patients with New Onset Chronic Graft Versus Host Disease (cGVHD)

Update Il y a 5 ans
Reference: EUCTR2016-003286-26

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of ibrutinib in combination with prednisone (Arm A) versus placebo in combination with prednisone (Arm B) based on the response rate at 24 weeks as determined by NIH Consensus Development Project criteria in subjects with new onset moderate to severe cGVHD.

Inclusion criteria

  • Chronic Graft Versus Host Disease (cGVHD)

Links